EGFR/HER2 Canine Cancer Vaccine Clinical Trial

EGFR/HER2 "Yale" VaccineПодробнее

A 3-yr survivor with osteosarcoma diagnosisПодробнее

Fighting canine osteosarcoma with stereotactic radiation therapy and immunotherapy.Подробнее

Immune Therapies in EGFR-Expressing CancersПодробнее

What EGFR/HER2 Vaccine TargetsПодробнее

EGFR/HER2 Yale Canine Cancer Vaccine Clinical TrialПодробнее

Yale Canine Cancer Vaccine - Prof. Mark MamulaПодробнее

EGFR / HER2 Vaccine Q&A | March 2023Подробнее

Prof Mamula - Canine Cancer Immunotherapy EGFR/HER2 Vaccine #ShortsПодробнее

EGFR/HER2 Vaccine - Clinical trial status (March 2023)Подробнее

The Status of Tina's Trial: Evaluating EGFR/HER2 Canine Cancer Vaccine for DogsПодробнее

A Seminar: Yale Canine Cancer Vaccine - Prof. Mark MamulaПодробнее